Literature DB >> 2460527

Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.

M Iwata1, K Ishizaka.   

Abstract

Attempts were made to generate Ag-specific suppressor T cells from Ag-primed spleen cells by using glycosylation inhibiting factor (GIF). BDF1 mice were primed with alum-absorbed OVA and their spleen cells were stimulated with OVA. Ag-activated T cells were then propagated in IL-2-containing conditioned medium. Incubation of the T cells with OVA-pulsed syngeneic macrophages resulted in the formation of IgE-potentiating factor and glycosylation-enhancing factor that has affinity for OVA, i.e., OVA-specific glycosylation-enhancing factor. However, if the same Ag-activated splenic T cells were propagated in the IL-2-containing medium in the presence of GIF T cells obtained in the cultures formed IgE-suppressive factors and OVA-specific GIF on antigenic stimulation. Thus we constructed T cell hybridomas from the Ag-activated T cells propagated by IL-2 in the presence of GIF. A representative hybridoma, 71B4, formed OVA-specific GIF on incubation with OVA-pulsed macrophages of BDF1 mice or C57B1/6 mice. However, if the same hybridoma cells were incubated with OVA alone or with OVA-pulsed macrophages of H-2k or H-2d strains, they produced GIF that had no affinity for OVA. The OVA-specific GIF bound to OVA-Sepharose but did not bind to BSA-Sepharose or KLH Sepharose. Intravenous injections of the OVA-specific GIF from the hybridoma suppressed the IgE and IgG1 anti-DNP antibody response of BDF1 mice to DNP-OVA, but failed to suppress the anti-hapten antibody responses of the strain to DNP-keyhole limpet hemocyanin, indicating that the factors suppressed the antibody response in a carrier-specific manner. However, the same OVA-specific GIF failed to suppress the anti-hapten antibody response of DBA/1 mice to DNP-OVA, suggesting that the immunosuppressive effects of the factors is MHC restricted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Authors:  Y Ishii; T Nakano; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Biochemical identification of glycosylation inhibiting factor.

Authors:  K Katamura; M Iwata; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Cloning and mapping of the mouse glycosylation-inhibiting factor gene and four related genes.

Authors:  N Honma; Y Matsuda; Y Ishii; M Sato; T Tomura; N Yuyama; T Mikayama
Journal:  Mamm Genome       Date:  1996-01       Impact factor: 2.957

4.  High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.

Authors:  K Sugie; T Nakano; T Tomura; K Takakura; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.

Authors:  T Nakano; H Watarai; Y C Liu; Y Oyama; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

6.  Biochemical characterization of murine glycosylation-inhibiting factor.

Authors:  Y Tagaya; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.

Authors:  T Mikayama; T Nakano; H Gomi; Y Nakagawa; Y C Liu; M Sato; A Iwamatsu; Y Ishii; W Y Weiser; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  The role of complement component C3b and its receptors in sperm-oocyte interaction.

Authors:  D J Anderson; A F Abbott; R M Jack
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

Authors:  Y C Liu; T Nakano; C Elly; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.

Authors:  H Gomi; Y Tagaya; T Nakano; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.